Articles Archives - Page 2 of 813

TuesdayJul 21, 2026 11:15 am

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Developing Two-Pronged Attack on Brain Disorders Affecting Millions

Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising. Quantum BioPharma's MS focus is Lucid-MS, a patented new chemical entity that takes a fundamentally different approach from existing therapies. Supporting Lucid-MS’s phase 2 development is an ongoing imaging collaboration with Massachusetts General Hospital. The company developed unbuzzd, a proprietary dietary supplement formulated to support alcohol metabolism and reduce the acute effects of intoxication and hangover. Neurological disorders affect hundreds of millions of people worldwide, and for many of those patients, existing treatments fall far short. Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM), a biopharmaceutical company, is…

TuesdayJul 21, 2026 10:30 am

American Fusion(TM) Inc. (AMFN) Secures Texas Certificate of Registration as Texatron(TM) Fusion Engine(TM) Testing Program Advances

The company has received a Texas DSHS Certificate of Registration for Industrial Radiation Machines, allowing research and development activities involving its registered Texatron(TM) Fusion Engine(TM) systems at Texas Tech University. The registration provides the principal regulatory authorization supporting the company's planned engineering, prototype testing, and validation roadmap, under applicable Texas radiation control regulations. The certificate covers 12 Texatron(TM) Fusion Engine(TM) research systems, ranging from 500 kW to 1 GW, reflecting the breadth of the company's planned development platform. The milestone follows months of regulatory review and supports the next phase of the company's technical development program, including calibration, diagnostics and…

TuesdayJul 21, 2026 9:45 am

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Hits Key Study Milestone as Early MS Imaging Data Shows Promising Signal

Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising. Multiple sclerosis is one of the most common neurological diseases affecting young adults worldwide. Study is evaluating technique that allows researchers to tell the difference between nerve damage that may still be reversible and damage that is permanent. Quantum BioPharma reports two key developments: patient enrollment in the pilot study has reached its halfway mark and preliminary imaging data is encouraging. A key imaging study examining a novel approach to tracking multiple sclerosis (“MS”) has reached its halfway point in patient enrollment, with early results…

TuesdayJul 21, 2026 9:00 am

BOXABL Inc. (NASDAQ: BXBL) Is ‘One to Watch’

BOXABL is advancing a factory-based approach to housing that seeks to standardize production and improve cost efficiency in a traditionally fragmented industry. The company is targeting a large addressable market supported by a significant housing supply gap and long-term affordability challenges. Its modular system is designed to scale across multiple use cases, from individual homes to large residential and commercial developments. The company is embedding automation and AI into factory operations to improve throughput, reduce defects, and optimize production efficiency. BOXABL’s model pairs lower-margin home production with higher-margin service opportunities such as financing, insurance, and maintenance. BOXABL (NASDAQ: BXBL) is a…

MondayJul 20, 2026 10:30 am

Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) Advances Schryburt Lake with New Independent Technical Report

Disseminated on behalf of Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) and may include paid advertising. The demand for key elements, including neodymium and praseodymium, and metals such as niobium, is only increasing. Canamera’s recent report recommends a diamond drill program of 1,500 meters across nine holes at its Schryburt Lake project. CEO states that “Schryburt Lake is a rare and genuinely underexplored carbonatite system in one of Canada's most active mining districts.” The magnets that spin electric vehicle motors and offshore wind turbines cannot be built without a small basket of rare earth elements led by neodymium and…

MondayJul 20, 2026 9:45 am

Earth Science Tech Inc. (ETST) Continues to Optimize Operational and Financial Frameworks to Maintain Its Singular Position of Strength

Earth Science Tech, a strategic holding company in the healthcare, pharmacy, and telemedicine sector, is distinct from other OTC listed companies based on its record of strong results, hard real estate assets, vertical integration, and robust corporate structure The company has reported year-over-year growth in revenue and gross profits since fiscal year 2024, progress attributable to careful strategic and complementary investments and acquisitions, which have not added debt to its balance sheet Its acquisition of Avenvi created a subsidiary that develops, manages, and finances real estate and owns property that houses ETST’s Texas pharmacy Investopedia lists the lack of reliable…

MondayJul 20, 2026 9:00 am

Greenland Mines Ltd. (NASDAQ: GRML) Ties Together Rare Earths, Advanced Materials in Single Share Exchange

Greenland Mines issued more than 12 million common shares to AnorTech, valued at approximately $3.5 million at closing. Anorthosite is a rock type abundant in Greenland and on the moon, and AnorTech is developing proprietary processes to extract high-value materials from it. The transaction moves Greenland closer to the midstream segment of the critical materials value chain. Two companies with deep roots in Greenland's mineral landscape have formalized a relationship that could reshape how each of them is valued. Greenland Mines (NASDAQ: GRML) has closed a strategic share exchange with AnorTech Inc. (TSX-V: ANOR; OTCQB: ANORF), a deal that gives…

FridayJul 17, 2026 9:45 am

SS Innovations International Inc. (NASDAQ: SSII) Strengthens Leadership as Global Robotic Surgery Expansion Gains Pace

The company has appointed veteran medtech finance executive Sarah M. Romano as Chief Financial Officer, effective August 3, 2026. Romano brings more than two decades of experience in public-company finance, capital markets, and medical technology, having raised more than $100 million during her career. The appointment comes as SS Innovations continues pursuing U.S. FDA clearance for its SSi Mantra surgical robotic system while expanding internationally. The company recently graduated the inaugural class of its SS International Centre for Robotics Surgery (“SSICRS”) cardiac robotic surgery training program. SSICRS welcomed 33 healthcare professionals from seven countries, underscoring the company's emphasis on surgeon…

FridayJul 17, 2026 9:00 am

Forward Industries Inc. (NASDAQ: FWDI) Now Holds Over 7.5 Million SOL as It Expands Solana Treasury in Fiscal Q3 2026

Forward Industries announced an expansion of its Solana treasury by over 500,000 Solana (SOL) during fiscal Q3 of 2026 at an average purchase price of around $79 per SOL. This brings Forward’s SOL treasury up to 7.55 million SOL as of June 30, 2026. During fiscal Q3, Forward sold 93,642 shares of common stock as part of its At The Market offering while delivering an annualized SOL-per-share growth of 36%. Forward Industries (NASDAQ: FWDI), which continues to build and manage a large-scale Solana (SOL) treasury, announced that it acquired more than 500,000 SOL during fiscal Q3 of 2026, at an…

ThursdayJul 16, 2026 10:30 am

American Fusion(TM) Inc. (AMFN) Advances North Texas Expansion as Texatron(TM) Testing and Patent Strategy Gains Momentum

The company has begun operations at its new North Texas engineering facility as it prepares to consolidate research, engineering and manufacturing activities. The relocation places the company closer to engineering talent, research institutions, aerospace companies and defense contractors in the Dallas-Fort Worth region. Expansion reflects American Fusion's(TM) strategy of combining engineering development, intellectual property protection, and prototype testing as it advances toward commercialization. The company is advancing preparations for testing both its 500 kW and 5 MW Texatron(TM) Fusion Engine(TM) platforms. Negotiations continue with Texas Tech University regarding access to specialized testing infrastructure for the Texatron(TM) development program. American Fusion(TM)…

Site Search

Company Search

Category: Articles